152 related articles for article (PubMed ID: 37480482)
1. Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.
Xu C; Xu T; Liu N; Liu L; Sun L; Li X; Li Z; Yao L
Int Urol Nephrol; 2024 Feb; 56(2):699-706. PubMed ID: 37480482
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of
Guo Y; Guo N; Wang J; Wang R; Tang L
Ren Fail; 2021 Dec; 43(1):729-736. PubMed ID: 33904354
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
4. Detection and clinical significance of glomerular M-type phospholipase A
Liu H; Luo W; Gong S; Ding X
Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
[TBL] [Abstract][Full Text] [Related]
6. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
[TBL] [Abstract][Full Text] [Related]
7. PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.
Huang Y; Zhou J; Zhou K; Huang B; Xue J; Zhang X; Liu B; Zhang Z; Zhou L; Cai T; Zhang Y; Hu Z; Wang L; Liu X
PeerJ; 2022; 10():e14193. PubMed ID: 36248712
[TBL] [Abstract][Full Text] [Related]
8. Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.
Jiang Z; Cai M; Dong B; Yan Y; Wang Y; Li X; Shao C; Zuo L
BMC Nephrol; 2021 Apr; 22(1):148. PubMed ID: 33888083
[TBL] [Abstract][Full Text] [Related]
9. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan.
Yamaguchi M; Ando M; Katsuno T; Tsuboi N; Maruyama S
Ren Fail; 2018 Nov; 40(1):435-441. PubMed ID: 30052488
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
11. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study.
Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L
Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568
[TBL] [Abstract][Full Text] [Related]
12. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
14. Serum anti-phospholipase A2 receptor antibody in pathological diagnosis of type 2 diabetes mellitus patients with proteinuria.
Zhang H; Zhu Y; Hu Z; Liu Q
Sci Rep; 2023 Oct; 13(1):16608. PubMed ID: 37789020
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
16. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y
Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930
[TBL] [Abstract][Full Text] [Related]
17. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
PLoS One; 2014; 9(10):e110681. PubMed ID: 25313791
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.
Dong L; Li YQ; Guo SM; Xu G; Wei W; Han M
Front Immunol; 2022; 13():905930. PubMed ID: 35784308
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
